Nebenwirkungen · Catiolanze
Catiolanze 50 micrograms/mL eye drops, emulsion · Abschnitt 4.8 · PDF-Seite 8
HOS-150352 · Präparat HOS-100296
In two short term clinical trials (≤12 weeks), involving 93 (25 and 68) paediatric patients treated with preserved latanoprost eye drops, solution, the safety profile was similar to that in adults and no new adverse events were identified. The short-term safety profiles in the different paediatric subsets were also similar (see section 4.2 and 5.1). Adverse events seen more frequently with preserved latanoprost in the paediatric population as compared to adults were nasopharyngitis and pyrexia.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-02-13T12:16:00Z · SHA-256 c0749d1a2aa165797afe68b3f55d2740a3ec8572146ef662a62d39cca9f9000d · Passage 9493459f931f3ca14cab2c818aebbc93d1532f51afd011223a1ae4fb6a11a27a · Zeichen 5524–6023 im Abschnitt